Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05315258
Title Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma (TebeMRD)
Acronym TebeMRD
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Oxford
Age Groups: adult | senior
Covered Countries GBR

No variant requirements are available.